Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colesevelam for Reducing PFAS Levels in Firefighters
NCT07226440Phase 2Recruiting
- Sponsor
- University of California, San Francisco
- Start
- Mar 2026
- Primary completion
- Dec 2028
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of colesevelam, sponsored by University of California, San Francisco. Started Mar 2026; status: recruiting.
02
Drugs
colesevelam
Beyond the preview
Go deeper on NCT07226440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07226440.